Copyright Reports & Markets. All rights reserved.

Global Oral Asthma Medications Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Oral Asthma Medications Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Tablets
    • 1.3.3 Capsules
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Oral Asthma Medications Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Anti-inflammatory
    • 1.4.3 Bronchodilators
    • 1.4.4 Combination Therapy
    • 1.4.5 Other
  • 1.5 Global Oral Asthma Medications Market Size & Forecast
    • 1.5.1 Global Oral Asthma Medications Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Oral Asthma Medications Sales Quantity (2020-2031)
    • 1.5.3 Global Oral Asthma Medications Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Teva Pharmaceutical
    • 2.1.1 Teva Pharmaceutical Details
    • 2.1.2 Teva Pharmaceutical Major Business
    • 2.1.3 Teva Pharmaceutical Oral Asthma Medications Product and Services
    • 2.1.4 Teva Pharmaceutical Oral Asthma Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Teva Pharmaceutical Recent Developments/Updates
  • 2.2 GSK
    • 2.2.1 GSK Details
    • 2.2.2 GSK Major Business
    • 2.2.3 GSK Oral Asthma Medications Product and Services
    • 2.2.4 GSK Oral Asthma Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 GSK Recent Developments/Updates
  • 2.3 Merck
    • 2.3.1 Merck Details
    • 2.3.2 Merck Major Business
    • 2.3.3 Merck Oral Asthma Medications Product and Services
    • 2.3.4 Merck Oral Asthma Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Merck Recent Developments/Updates
  • 2.4 Roche
    • 2.4.1 Roche Details
    • 2.4.2 Roche Major Business
    • 2.4.3 Roche Oral Asthma Medications Product and Services
    • 2.4.4 Roche Oral Asthma Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Roche Recent Developments/Updates
  • 2.5 AstraZeneca
    • 2.5.1 AstraZeneca Details
    • 2.5.2 AstraZeneca Major Business
    • 2.5.3 AstraZeneca Oral Asthma Medications Product and Services
    • 2.5.4 AstraZeneca Oral Asthma Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 AstraZeneca Recent Developments/Updates
  • 2.6 Boehringer Ingelheim International
    • 2.6.1 Boehringer Ingelheim International Details
    • 2.6.2 Boehringer Ingelheim International Major Business
    • 2.6.3 Boehringer Ingelheim International Oral Asthma Medications Product and Services
    • 2.6.4 Boehringer Ingelheim International Oral Asthma Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Boehringer Ingelheim International Recent Developments/Updates
  • 2.7 Sanofi
    • 2.7.1 Sanofi Details
    • 2.7.2 Sanofi Major Business
    • 2.7.3 Sanofi Oral Asthma Medications Product and Services
    • 2.7.4 Sanofi Oral Asthma Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Sanofi Recent Developments/Updates
  • 2.8 BD
    • 2.8.1 BD Details
    • 2.8.2 BD Major Business
    • 2.8.3 BD Oral Asthma Medications Product and Services
    • 2.8.4 BD Oral Asthma Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 BD Recent Developments/Updates
  • 2.9 Covis Pharma
    • 2.9.1 Covis Pharma Details
    • 2.9.2 Covis Pharma Major Business
    • 2.9.3 Covis Pharma Oral Asthma Medications Product and Services
    • 2.9.4 Covis Pharma Oral Asthma Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Covis Pharma Recent Developments/Updates

3 Competitive Environment: Oral Asthma Medications by Manufacturer

  • 3.1 Global Oral Asthma Medications Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Oral Asthma Medications Revenue by Manufacturer (2020-2025)
  • 3.3 Global Oral Asthma Medications Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Oral Asthma Medications by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Oral Asthma Medications Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Oral Asthma Medications Manufacturer Market Share in 2024
  • 3.5 Oral Asthma Medications Market: Overall Company Footprint Analysis
    • 3.5.1 Oral Asthma Medications Market: Region Footprint
    • 3.5.2 Oral Asthma Medications Market: Company Product Type Footprint
    • 3.5.3 Oral Asthma Medications Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Oral Asthma Medications Market Size by Region
    • 4.1.1 Global Oral Asthma Medications Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Oral Asthma Medications Consumption Value by Region (2020-2031)
    • 4.1.3 Global Oral Asthma Medications Average Price by Region (2020-2031)
  • 4.2 North America Oral Asthma Medications Consumption Value (2020-2031)
  • 4.3 Europe Oral Asthma Medications Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Oral Asthma Medications Consumption Value (2020-2031)
  • 4.5 South America Oral Asthma Medications Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Oral Asthma Medications Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Oral Asthma Medications Sales Quantity by Type (2020-2031)
  • 5.2 Global Oral Asthma Medications Consumption Value by Type (2020-2031)
  • 5.3 Global Oral Asthma Medications Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Oral Asthma Medications Sales Quantity by Application (2020-2031)
  • 6.2 Global Oral Asthma Medications Consumption Value by Application (2020-2031)
  • 6.3 Global Oral Asthma Medications Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Oral Asthma Medications Sales Quantity by Type (2020-2031)
  • 7.2 North America Oral Asthma Medications Sales Quantity by Application (2020-2031)
  • 7.3 North America Oral Asthma Medications Market Size by Country
    • 7.3.1 North America Oral Asthma Medications Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Oral Asthma Medications Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Oral Asthma Medications Sales Quantity by Type (2020-2031)
  • 8.2 Europe Oral Asthma Medications Sales Quantity by Application (2020-2031)
  • 8.3 Europe Oral Asthma Medications Market Size by Country
    • 8.3.1 Europe Oral Asthma Medications Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Oral Asthma Medications Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Oral Asthma Medications Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Oral Asthma Medications Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Oral Asthma Medications Market Size by Region
    • 9.3.1 Asia-Pacific Oral Asthma Medications Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Oral Asthma Medications Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Oral Asthma Medications Sales Quantity by Type (2020-2031)
  • 10.2 South America Oral Asthma Medications Sales Quantity by Application (2020-2031)
  • 10.3 South America Oral Asthma Medications Market Size by Country
    • 10.3.1 South America Oral Asthma Medications Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Oral Asthma Medications Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Oral Asthma Medications Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Oral Asthma Medications Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Oral Asthma Medications Market Size by Country
    • 11.3.1 Middle East & Africa Oral Asthma Medications Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Oral Asthma Medications Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Oral Asthma Medications Market Drivers
  • 12.2 Oral Asthma Medications Market Restraints
  • 12.3 Oral Asthma Medications Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Oral Asthma Medications and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Oral Asthma Medications
  • 13.3 Oral Asthma Medications Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Oral Asthma Medications Typical Distributors
  • 14.3 Oral Asthma Medications Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Oral Asthma Medications market size was valued at US$ 715 million in 2024 and is forecast to a readjusted size of USD 1041 million by 2031 with a CAGR of 5.6% during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Oral asthma medications play a critical role in managing asthma, particularly for patients who require additional control beyond inhaled therapies or who have difficulty using inhalers. These medications include leukotriene modifiers (e.g., montelukast), which help reduce inflammation and bronchoconstriction by blocking leukotrienes, and oral corticosteroids (e.g., prednisone), used for short-term management of severe exacerbations due to their potent anti-inflammatory effects.
    This report is a detailed and comprehensive analysis for global Oral Asthma Medications market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Oral Asthma Medications market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Oral Asthma Medications market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Oral Asthma Medications market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Oral Asthma Medications market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Oral Asthma Medications
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Oral Asthma Medications market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva Pharmaceutical, GSK, Merck, Roche, AstraZeneca, Boehringer Ingelheim International, Sanofi, BD, Covis Pharma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Oral Asthma Medications market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Tablets
    Capsules
    Market segment by Application
    Anti-inflammatory
    Bronchodilators
    Combination Therapy
    Other
    Major players covered
    Teva Pharmaceutical
    GSK
    Merck
    Roche
    AstraZeneca
    Boehringer Ingelheim International
    Sanofi
    BD
    Covis Pharma
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Oral Asthma Medications product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Oral Asthma Medications, with price, sales quantity, revenue, and global market share of Oral Asthma Medications from 2020 to 2025.
    Chapter 3, the Oral Asthma Medications competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Oral Asthma Medications breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Oral Asthma Medications market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Asthma Medications.
    Chapter 14 and 15, to describe Oral Asthma Medications sales channel, distributors, customers, research findings and conclusion.

    Buy now